$71.9 Million is the total value of Bratton Capital Management, L.P.'s 2 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AQST | AQUESTIVE THERAPEUTICS INC | $55,848,000 | -0.1% | 11,503,294 | 0.0% | 77.67% | -7.3% | |
| DNLI | DENALI THERAPEUTICS INC | $16,053,000 | +48.2% | 448,035 | 0.0% | 22.33% | +37.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AQUESTIVE THERAPEUTICS INC | 20 | Q3 2023 | 100.0% |
| DENALI THERAPEUTICS INC | 8 | Q3 2020 | 39.8% |
View Bratton Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View Bratton Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.